Menopause and Optimizing Midlife Health of Women, 17586-17587 [2023-05984]

Download as PDF 17586 Federal Register / Vol. 88, No. 56 / Thursday, March 23, 2023 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES National Advisory Committee on Individuals With Disabilities and Disasters Administration for Strategic Preparedness and Response (ASPR), Department of Health and Human Services (HHS). ACTION: Notice. AGENCY: The National Advisory Committee on Individuals with Disabilities and Disasters (NACIDD or the Committee) is required by the PHS Act as amended by the Pandemic and All Hazards Preparedness and Advancing Innovation Act (PAHPAIA) and governed by the provisions of the Federal Advisory Committee Act (FACA). The NACIDD shall evaluate issues and programs and provide findings, advice, and recommendations to the Secretary of HHS and ASPR to support and enhance all-hazards public health and medical preparedness, response, and recovery aimed at meeting the needs of people with disabilities. The Secretary of HHS has delegated authority to operate the NACIDD to ASPR. DATES: The NACIDD will conduct a public meeting (virtual) on April 20, 2023, to discuss, finalize, and vote on an initial set of recommendations to the HHS Secretary and ASPR regarding challenges, opportunities, and priorities for national public health and medical preparedness, response, and recovery, specific to the needs of people with disabilities in disasters. A more detailed agenda and meeting registration link will be available on the NACIDD meeting website located at: https:// www.phe.gov/nacidd. ADDRESSES: Members of the public may attend the meeting via a toll-free phone number or Zoom teleconference, which requires pre-registration. The meeting link to pre-register will be posted on https://www.phe.gov/nacidd. Members of the public may provide written comments or submit questions for consideration to the NACIDD at any time via email to NACIDD@hhs.gov. Members of the public are also encouraged to provide comments after the meeting. FOR FURTHER INFORMATION CONTACT: Tabinda Burney, NACIDD Designated Federal Officer, Administration for Strategic Preparedness and Response (ASPR), Department of Health and Human Services (HHS), Washington, DC; 202–699–1779, NACIDD@hhs.gov. SUPPLEMENTARY INFORMATION: The NACIDD invites those who are involved ddrumheller on DSK120RN23PROD with NOTICES1 SUMMARY: VerDate Sep<11>2014 19:23 Mar 22, 2023 Jkt 259001 in or represent a relevant industry, academia, profession, organization, or U.S. state, Tribal, territorial, or local government to request up to four minutes to address the committee live via Zoom. Requests to provide remarks to the NACIDD during the public meeting must be sent to NACIDD@ hhs.gov at least 15 days prior to the meeting along with a brief description of the topic. We would specifically like to request inputs from the public on challenges in disaster training, opportunities, and strategic priorities for national public health and medical preparedness, response, and recovery specific to the needs of people with disabilities before, during, and after disasters. Slides, documents, and other presentation material sent along with the request to speak will be provided to the committee members separately. Please indicate additionally whether the presenter will be willing to take questions from the committee members (at their discretion) immediately following their presentation (for up to four additional minutes). Dawn O’Connell, Assistant Secretary for Preparedness and Response. [FR Doc. 2023–05976 Filed 3–22–23; 8:45 am] BILLING CODE 4150–37–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR Panel: Fogarty Global Brain Disorders. Date: April 17, 2023. Time: 2:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). PO 00000 Frm 00071 Fmt 4703 Sfmt 4703 Contact Person: Todd Everett White, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594–3962, todd.white@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: March 20, 2023. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2023–05967 Filed 3–22–23; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Menopause and Optimizing Midlife Health of Women AGENCY: National Institutes of Health, HHS. ACTION: Notice. This symposium is sponsored by the NIH Office of Research on Women’s Health (ORWH), the title of this year’s symposium is ‘‘Menopause and Optimizing Midlife Health of Women.’’ The symposium will discuss menopausal transition, accumulation of morbidity after menopause, menopause in special populations, social determinants of health, menopausal hormonal therapy, and interventions to promote healthy aging. DATES: The meeting will be held on May 16, 2023, from 10 a.m. to 5 p.m. ADDRESSES: The meeting will be virtual. Registration is available at https:// nih.zoomgov.com/webinar/register/WN_ YMa1r3QbSsiQ8scHfc4ixA. The meeting is viewable on NIH Videocast at https://videocast.nih.gov/watch=49307; no registration required. FOR FURTHER INFORMATION CONTACT: For information concerning this meeting, see the ORWH website, https:// orwh.od.nih.gov/about/newsroom/ events/7th-annual-vivian-w-pinnsymposium, or contact Dr. Sarah Temkin, Associate Director for Clinical Research, Office of Research on Women’s Health, 6707 Democracy Boulevard, Suite 400, Bethesda, MD 20817, telephone: 301–402–1770; email: sarah.temkin@nih.gov. SUPPLEMENTARY INFORMATION: This Notice is in accordance with 42 U.S.C. 287d, of the Public Health Service Act, as amended. The 7th Annual Vivian W. Pinn Symposium honors the first fullSUMMARY: E:\FR\FM\23MRN1.SGM 23MRN1 Federal Register / Vol. 88, No. 56 / Thursday, March 23, 2023 / Notices time director of ORWH, Dr. Vivian Pinn, and is held during National Women’s Health Week. This event serves as a critical forum for experts across sectors to communicate and collaborate for the advancement of women’s health. Providing the keynote address, ‘‘Menopausal Hormone Therapy: 30 Years of Lessons from the Women’s Health Initiative,’’ is JoAnn Manson, M.D., Professor of Medicine at Harvard Medical School and Chief of the Division of Preventive Medicine, Department of Medicine at Brigham and Women’s Hospital. A patient advocacy panel will discuss the patient perspective of menopause. The objectives of the symposium are to: • Familiarize attendees with state of the science related to our understanding of risk factors and mechanisms that lead to reproductive aging. • Understand women’s unique morbidity and multimorbidity burden to identify points of intervention. • Identify the needs of populations at risk for iatrogenic menopause (patients with germline inherited cancer risk) and early or complex menopausal symptoms (patients living with HIV, chronic conditions, and cancer). • Identify priorities to address unmet environmental and other exposures as it relates to menopausal transition and symptoms in diverse populations of women. • Understand current recommendations on menopausal hormone therapy prescribing including when to start and stop, and formulations and durations of use. Interested individuals can register at: https://nih.zoomgov.com/webinar/ register/WN_YMa1r3QbSsi Q8scHfc4ixA. More information about the speakers and agenda can be found at https://orwh.od.nih.gov/about/ newsroom/events/7th-annual-vivian-wpinn-symposium. This event is free. Dated: March 17, 2023. Tara A. Schwetz, Acting Principal Deputy Director, National Institutes of Health. [FR Doc. 2023–05984 Filed 3–22–23; 8:45 am] ddrumheller on DSK120RN23PROD with NOTICES1 BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as VerDate Sep<11>2014 19:23 Mar 22, 2023 Jkt 259001 amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Topics in Neurological Injuries and Disorders. Date: April 11, 2023. Time: 11:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Christine Jean DiDonato, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 1014J, Bethesda, MD 20892, (301) 435–1042, didonatocj@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: March 20, 2023. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2023–05975 Filed 3–22–23; 8:45 am] 17587 would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Biomedical Informatics, Library and Data Sciences Review Committee (BILDS). Date: June 15–16, 2023. Time: June 15, 2023, 10:30 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Library of Medicine, 6705 Rockledge Drive, Bethesda, MD 20892 (Video Assisted Meeting). Time: June 16, 2023, 10:00 a.m. to 11:00 a.m. Agenda: To review and evaluate grant applications. Place: National Library of Medicine, 6705 Rockledge Drive, Bethesda, MD 20892 (Video Assisted Meeting). Contact Person: Zoe E. Huang, MD, Chief Scientific Review Officer, Scientific Review Office, Extramural Programs, National Library of Medicine, National Institutes of Health (NIH), 6705 Rockledge Drive, Suite 500, Bethesda, MD 20892–7968, 301–594– 4937, huangz@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program No. 93.879, Medical Library Assistance, National Institutes of Health, HHS) Dated: March 20, 2023. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2023–05969 Filed 3–22–23; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Library of Medicine; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the meeting of the Biomedical Informatics, Library and Data Sciences Review Committee. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable materials, and personal information concerning individuals associated with the grant applications, the disclosure of which PO 00000 Frm 00072 Fmt 4703 Sfmt 4703 National Library of Medicine; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable materials, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Library of Medicine Special Emphasis Panel; G08. Date: June 16, 2023. Time: 12:00 p.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. E:\FR\FM\23MRN1.SGM 23MRN1

Agencies

[Federal Register Volume 88, Number 56 (Thursday, March 23, 2023)]
[Notices]
[Pages 17586-17587]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-05984]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Menopause and Optimizing Midlife Health of Women

AGENCY: National Institutes of Health, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This symposium is sponsored by the NIH Office of Research on 
Women's Health (ORWH), the title of this year's symposium is 
``Menopause and Optimizing Midlife Health of Women.'' The symposium 
will discuss menopausal transition, accumulation of morbidity after 
menopause, menopause in special populations, social determinants of 
health, menopausal hormonal therapy, and interventions to promote 
healthy aging.

DATES: The meeting will be held on May 16, 2023, from 10 a.m. to 5 p.m.

ADDRESSES: The meeting will be virtual. Registration is available at 
https://nih.zoomgov.com/webinar/register/WN_YMa1r3QbSsiQ8scHfc4ixA. The 
meeting is viewable on NIH Videocast at https://videocast.nih.gov/watch=49307; no registration required.

FOR FURTHER INFORMATION CONTACT: For information concerning this 
meeting, see the ORWH website, https://orwh.od.nih.gov/about/newsroom/events/7th-annual-vivian-w-pinn-symposium, or contact Dr. Sarah Temkin, 
Associate Director for Clinical Research, Office of Research on Women's 
Health, 6707 Democracy Boulevard, Suite 400, Bethesda, MD 20817, 
telephone: 301-402-1770; email: [email protected].

SUPPLEMENTARY INFORMATION: This Notice is in accordance with 42 U.S.C. 
287d, of the Public Health Service Act, as amended. The 7th Annual 
Vivian W. Pinn Symposium honors the first full-

[[Page 17587]]

time director of ORWH, Dr. Vivian Pinn, and is held during National 
Women's Health Week. This event serves as a critical forum for experts 
across sectors to communicate and collaborate for the advancement of 
women's health.
    Providing the keynote address, ``Menopausal Hormone Therapy: 30 
Years of Lessons from the Women's Health Initiative,'' is JoAnn Manson, 
M.D., Professor of Medicine at Harvard Medical School and Chief of the 
Division of Preventive Medicine, Department of Medicine at Brigham and 
Women's Hospital. A patient advocacy panel will discuss the patient 
perspective of menopause.
    The objectives of the symposium are to:
     Familiarize attendees with state of the science related to 
our understanding of risk factors and mechanisms that lead to 
reproductive aging.
     Understand women's unique morbidity and multimorbidity 
burden to identify points of intervention.
     Identify the needs of populations at risk for iatrogenic 
menopause (patients with germline inherited cancer risk) and early or 
complex menopausal symptoms (patients living with HIV, chronic 
conditions, and cancer).
     Identify priorities to address unmet environmental and 
other exposures as it relates to menopausal transition and symptoms in 
diverse populations of women.
     Understand current recommendations on menopausal hormone 
therapy prescribing including when to start and stop, and formulations 
and durations of use.
    Interested individuals can register at: https://nih.zoomgov.com/webinar/register/WN_YMa1r3QbSsiQ8scHfc4ixA. More information about the 
speakers and agenda can be found at https://orwh.od.nih.gov/about/newsroom/events/7th-annual-vivian-w-pinn-symposium. This event is free.

    Dated: March 17, 2023.
Tara A. Schwetz,
Acting Principal Deputy Director, National Institutes of Health.
[FR Doc. 2023-05984 Filed 3-22-23; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.